Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
Relevance of intraocular involvement in the management of primary central nervous system lymphomas
A J M Ferreri, J Y Blay, M Reni, et al.
Current Drug Targets
|
August 12, 2009
Recent advances in targeted anti-vasculature therapy: the neuroblastoma model
F Pastorino, D Di Paolo, M Loi, et al.
Histopathology
|
April 21, 2006
The prevalence and clinical implications of c-kit expression in plasma cell myeloma
G Pruneri, M Ponzoni, A J M Ferreri, et al.
Leukemia
|
October 26, 2011
Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation
A Dagklis, M Ponzoni, S Govi, et al.
Oncogene
|
January 16, 2013
Dual regulation of Myc by Abl
V J Sanchez-Arévalo Lobo, M Doni, A Verrecchia, et al.
Virchows Archiv : an International Journal of Pathology
|
August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology
|
October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
The Journal of Pathology
|
October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
S Tedoldi, A Mottok, J Ying, et al.
Journal of Clinical Pathology
|
June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
E Frei, C Visco, Z Y Xu-Monette, et al.
Leukemia
|
June 1, 2019
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
M Frenquelli, N Caridi, E Antonini, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
Relevance of intraocular involvement in the management of primary central nervous system lymphomas
A J M Ferreri, J Y Blay, M Reni, et al.
Current Drug Targets
|
August 12, 2009
Recent advances in targeted anti-vasculature therapy: the neuroblastoma model
F Pastorino, D Di Paolo, M Loi, et al.
Histopathology
|
April 21, 2006
The prevalence and clinical implications of c-kit expression in plasma cell myeloma
G Pruneri, M Ponzoni, A J M Ferreri, et al.
Leukemia
|
October 26, 2011
Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation
A Dagklis, M Ponzoni, S Govi, et al.
Oncogene
|
January 16, 2013
Dual regulation of Myc by Abl
V J Sanchez-Arévalo Lobo, M Doni, A Verrecchia, et al.
Virchows Archiv : an International Journal of Pathology
|
August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology
|
October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
The Journal of Pathology
|
October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
S Tedoldi, A Mottok, J Ying, et al.
Journal of Clinical Pathology
|
June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
E Frei, C Visco, Z Y Xu-Monette, et al.
Leukemia
|
June 1, 2019
The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
M Frenquelli, N Caridi, E Antonini, et al.
Page
of 12